The CD-Laboratory for Innovative Therapy Approaches in Sepsis (commercial partner: Fresenius Medical Care) aims at the development of supportive therapies for sepsis, focusing on the following aspects:

  1. Extracorporeal therapies as supportive options in sepsis (e.g. high cut-off filters, extracorporeal adsorption of inflammatory mediators)
  2. Endothelial activation in sepsis (cell culture models, influence of cytokine modulation on endothelial activation)
  3. Role of extracellular vesicles in sepsis and inflammation (characterization of extracellular vesicles in body fluids, in particular in whole blood, influence of pre-analytical parameters, thrombogenicity of extracellular vesicles, immunomodulation, interaction with blood cells; characterization of EVs from other sources).
  4. Development of blood compatible polymers: increase of blood compatibility of adsorbents, e.g. by zwitterionic coatings.
  5. Development of improved methods for pathogen detecion (within the project Smartdiagnos).

More information is available at

Funding: Christian Doppler Research  Association         Cd-gesellschaft

                Fresenius Medical Care


Duration 01/01/2013 - 31/12/2019
Funding sonstige öffentlich-rechtliche Einrichtungen (Körperschaften, Stiftungen, Fonds)
Program CD-Labor

Department for Biomedical Research

Center for Biomedical Technology

Principle investigator for the project (University for Continuing Education Krems) Univ.-Prof. Dr. Viktoria Weber

Project Manager

Back to top